EMBC
Embecta Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.29
+1.93%Forward multiples
Based on analyst estimates
- P/E forward
- 3.29x
- P/E 2026E
- 2.79x
- P/E 2027E
- 2.90x
- P/E 2028E
- 2.62x
- P/S forward
- 0.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.55x
- PEG TTM
- 0.44x
- Price / book
- -0.49x
- Price / sales
- 0.29x
- Price / cash flow
- 1.72x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 1.56x
- EV / EBITDA
- 5.80x
- EV / EBIT
- 6.27x
- Market cap
- $299.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026